Скачать или смотреть Insulin Prices Could Be Much Lower

Insulin Prices Could Be Much Lower
High prices for insulin pose a barrier to treatment for people living with diabetes, with an estimated 50% of 100 million patients needing insulin lacking reliable access. As insulin analogues replace regular human insulin (RHI) globally, their relative prices will become increasingly important. Three originator companies control 96% of the global insulin market, and few biosimilar insulins are available. We estimated the price reductions that could be achieved if numerous biosimilar manufacturers entered the insulin market.Data on the price of active pharmaceutical ingredient (API) exported from India were retrieved from an online customs database. Manufacturers of insulins were contacted for price quotes. Where market API prices could not be identified, prices were estimated based on comparison of similarity, in terms of manufacturing process, with APIs for which prices were available. Potential biosimilar prices were estimated by adding costs of excipients, formulation, transport, development and regulatory costs, and a profit margin.




======================================
TO_OWNERS_AND_COPYRIGHT: This channel is created to promote the best informative videos
releated Health Technology Science nature
performers,and producers. We do not want to violate copyrights.
IF_YOU_WANT_TO_DELETE_THIS_VIDEO,
please let us know - we can immediately remove it from our channel.
[email protected]

this_video_credit_goes_to
Hashem Al Ghailli
youtube channel
   / hashemalghaili  
facebook
  / sciencenaturepage  
subscribe our channel for more informative videos
   / @insidehuman9183  
Google plus
https://plus.google.com/1023328711303...
======================================